DOC PREVIEW
Clemson BIOL 4610 - The EFG Receptor
Type Lecture Note
Pages 3

This preview shows page 1 out of 3 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 3 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 3 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

BIOL 4610 1st Edition Lecture 17Outline of Current Lecture1. Example of an RTK is the EGF receptor2. HER2 amplification in breast cancer3. The Ras/MAP kinase pathway4. RTKs and cytokine receptors linked to Ras by adapter proteins-GRB2 and Sos5. Transcription factors controlled by MAP kinase include c-fos and c-junCurrent Lecture1. Example of an RTK is the EGF receptor - the HER family – (human epidermal growth factor receptor)In humans, have 4 different isoforms of EGF receptor. Just called 1 2 3, 4. All bind to the epidermal growth factor signal. HER 1- dimerizes and binds to another HER 1 (homodimers)Heterodimers (HER 1 and HER 2)HER 3 has no activation Lip (doesn’t act as a kinase) so must bind to another HER with an activekinase domain to phosphorylate. HER 2 has no ligan binding; it’s in a pre-activated state so loops always extended; don’t need a signal so it’s constantly being told to divide divide divide. So cells deal with this by receptors only being expressed at a given time. 2. HER2 amplification in breast cancer and median survival rateHER 2- normally expressed at very low levels and in tissue-specific manner. (Ex. Breast tissue)Amplification- more copies in chromosome, so it makes too many proteinsThese notes represent a detailed interpretation of the professor’s lecture. GradeBuddy is best used as a supplement to your own notes, not as a substitute.Epidemiological study Data shows that since HER 2 exists in active state, it doesn’t need a signal and constantly divides. HER 2 has no ligand binding domainHerceptin- antibody that targets the extracellular domain (loop) and prevents dimerization. This is the first drug you would get if you had HER 2 breast cancer. 16.2. The Ras/MAP kinase pathwayRas: monomeric GTPase - Bound to GDP in inactive state- Bound to GTP in active state- Require guanine exchange factor GEF in order to remove the GDP and allow GTP to bind.- Ras’s GEF is Sos.- Ras’s GTPase activity is very slow (~1 minute to cleave off GTP à GDP)- Needs GAP (GTPase Acceleration Protein) - Raf is one of Ras’s GAP- Ras is one of most frequently mutated proteinsRTKs and cytokine receptors linked to Ras by adapter proteins-GRB2 and SosEGF receptor - Bound by ligand- Dimerized- P tyrosines- GRB2 has 2 domains:1. SH2 Domain- bind to phoshorylated tyrosines2. SH3 domain- bind to areas rich in prolinesSos: 1. Proline rich domain (bind with GRB2)2. GEF - activityStarts a cascade of protein kinases- active RasRas recruits a protein called Raf -binds to active Ras and phosphorylates itself-Raf acts as the GAP proteinReleases phosphorylated Raf from Ras-get an active kinase in the cytoplasmNow we can start moving away from membrane and get to nucleusTranscription factors controlled by MAP kinase include c-fos and c-junMAP kinase can act as a transcription factor when phosphorylated Also phosphorylates P-90 à comes into nucleus and phosphorylates SRFFinal proteins made (target proteins that get transcribed at the end of the EGF-Ras-MAP kinase pathway)This helps start S phase of the cell


View Full Document

Clemson BIOL 4610 - The EFG Receptor

Type: Lecture Note
Pages: 3
Download The EFG Receptor
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view The EFG Receptor and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view The EFG Receptor 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?